Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Detalles Bibliográficos
Autores principales: Pepper, Andrea G. S., Zucchetto, Antonella, Norris, Kevin, Tissino, Erika, Polesel, Jerry, Soe, Zarni, Allsup, David, Hockaday, Anna, Ow, Pei Loo, Hillmen, Peter, Rawstron, Andrew, Catovsky, Daniel, Bulian, Pietro, Bomben, Riccardo, Baird, Duncan M., Fegan, Christopher D., Gattei, Valter, Pepper, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727296/
https://www.ncbi.nlm.nih.gov/pubmed/34148055
http://dx.doi.org/10.1038/s41375-021-01322-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727296/
https://www.ncbi.nlm.nih.gov/pubmed/34148055
http://dx.doi.org/10.1038/s41375-021-01322-1

Ejemplares similares